By Erica Teichert ( July 23, 2012, 1:52 PM EDT) -- K-V Pharmaceutical Co. can't force the U.S. Food and Drug Administration to crack down on cheaper compounded alternatives of the manufacturer's premature birth prevention drug Makena since FDA enforcement decisions aren't eligible for judicial review, the agency told a Washington federal court on Friday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.